$AVNR AVANIR PHARMACEUTICALS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AVANIR PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AVANIR PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in AVANIR PHARMACEUTICALS, INC. for free.
IRS Number: 330314804
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AVNR
Company Address: 20 ENTERPRISE SUITE 200 ALISO VIEJO 92656
Former name: LIDAK PHARMACEUTICALS, date of change: 1992-07-03
Former name: AVANIR PHARMACEUTICALS, date of change: 1998-12-07
Prev close: $0.00
Average Daily Volume: 8,292,970
Days Low: $0.00
Year Low: $3.00
Year High: $17.00
AVANIR PHARMACEUTICALS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2014 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Option Exercise | M | 2.59 | 32,291 | 83,634 | 0 | |
| Dec 22 2014 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Sell | S | 16.93 | 15,505 | 262,500 | 314,192 | 329.7 K to 314.2 K (-4.70 %) |
| Dec 22 2014 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Payment of Exercise | F | 16.99 | 19,204 | 326,276 | 329,697 | 348.9 K to 329.7 K (-5.50 %) |
| Dec 22 2014 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Buy | M | 2.59 | 32,291 | 83,634 | 348,901 | 316.6 K to 348.9 K (+10.20 %) |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 4.18 | 17,500 | 73,150 | 0 | |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 2.59 | 12,500 | 32,375 | 17,500 | |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 16.93 | 5,780 | 97,855 | 108,797 | 114.6 K to 108.8 K (-5.04 %) |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 16.94 | 17,500 | 296,450 | 114,577 | 132.1 K to 114.6 K (-13.25 %) |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 16.94 | 12,500 | 211,750 | 132,077 | 144.6 K to 132.1 K (-8.65 %) |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 4.18 | 17,500 | 73,150 | 144,577 | 127.1 K to 144.6 K (+13.77 %) |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 2.59 | 12,500 | 32,375 | 127,077 | 114.6 K to 127.1 K (+10.91 %) |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 1.74 | 139,200 | 242,208 | 976,769 | |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 1.29 | 55,960 | 72,188 | 976,769 | |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 16.93 | 62,520 | 1,058,464 | 914,249 | 976.8 K to 914.2 K (-6.40 %) |
| Dec 18 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 16.95 | 195,160 | 3,307,962 | 976,769 | 1.2 M to 976.8 K (-16.65 %) |